A study conducted to evaluate the action of bergamot extract (650, 1300 mg, and placebo) on MetS risk factors, showed an improvement in the lipid profile, a reduction in FBG, HOMA-IR, and insulin. The gene discussed is INS; the disease is metabolic syndrome.